biosimilars

Amgen And Daiichi Sankyo Announce Agreement To Commercialize Biosimilars In Japan
Yahoo
Thu, 07/14/16 - 10:11 am
Amgen
Daiichi Sankyo
Japan
biosimilars
Sandoz Enbrel biosim cruises at FDA panel, endangering key Amgen sales
Fierce Pharma
Wed, 07/13/16 - 06:22 pm
Sandoz
Novartis
FDA
advisory panels
biosimilars
Enbrel
Amgen
FDA Panel Resoundingly Backs Amgen's Biosimilar Humira
Investors.com
Tue, 07/12/16 - 07:03 pm
FDA
advisory panels
Amgen
biosimilars
Humira
ABP 501
FDA panel to review Humira, Enbrel biosimilars this week
BioPharma Dive
Tue, 07/12/16 - 09:22 am
FDA
advisory panels
Humira
Enbrel
biosimilars
ABP-501
Amgen
AbbVie
GP2015
Novartis
Amgen drug appears 'highly similar' to Humira -FDA staff
Yahoo/Reuters
Fri, 07/8/16 - 10:23 am
Amgen
Humira
FDA
Enbrel
rheumatoid arthritis
ABP 501
biosimilars
Eli Lilly Launches Lantus Biosimilar To Boost Sales, But Not Without Risks
Seeking Alpha
Tue, 06/28/16 - 05:33 pm
Eli Lilly
Lantus
biosimilars
diabetes
Basaglar
A bill would would speed cheaper versions of pricey biologics to market
Stat
Thu, 06/23/16 - 08:16 pm
biologics
congress
biosimilars
Amgen, Novartis Court Case May Ease US Launch of Biosimilars
Bidness, ETC
Thu, 06/23/16 - 09:56 am
Amgen
Novartis
biosimilars
Zarxio
Supreme Court
Novartis aims to nearly triple biosimilar drugs on market by 2020
Yahoo/Reuters
Mon, 06/20/16 - 10:34 am
Novartis
biosimilars
Will the approval of Inflectra be a biosimilar adoption tipping point?
BioPharma Dive
Fri, 06/10/16 - 10:18 am
Inflectra
biosimilars
Celltrion
Remicade
JNJ
rheumatoid arthritis
Hunting growth, Samsung races to get up to speed on biosimilar drugs
Yahoo/Reuters
Tue, 06/7/16 - 11:15 am
Samsung Bioepis
biosimilars
How Mylan Is Taking On One of the World's Top Breast Cancer Drugs
Fortune
Mon, 06/6/16 - 10:36 am
Roche
breast cancer
Herceptin
biosimilars
Mylan Labs
Novartis CEO eyes biosimilar plays in Asia that fit with Sandoz plans
Fierce Pharma
Fri, 06/3/16 - 09:53 am
Novartis
Pharma CEOs
Joe Jimenez
Asia
Sandoz
biosimilars
Samsung Bioepis notches European Commission nod for Remicade biosim
Fierce Pharma
Mon, 05/30/16 - 11:05 am
Samsung Bioepis
Europe
Flixabi
Remicade
biosimilars
JNJ
Roche's Hematology Franchise Almost 100% Protected From Biosimilars
Seeking Alpha
Fri, 05/27/16 - 10:59 pm
Roche
hematology
biosimilars
Gazyva
Rituxan
Merck educates doctors about biosimilars, long before it will sell one in the U.S.
Medical Marketing and Media
Wed, 05/25/16 - 11:48 am
Merck
physicians
biosimilars
Samsung Bioepis applies for approval to sell Remicade biosimilar in U.S.
Yahoo/Reuters
Mon, 05/23/16 - 09:41 pm
Samsung Bioepis
Remicade
biosimilars
FDA
rheumatoid arthritis
JNJ
Epirus exec sees promise for biosimilars despite setback for company
Bizjournals.com
Wed, 05/11/16 - 06:40 pm
Epirius
biosimilars
Infographic: the growing biosimilar market in the U.S.
Medical Marketing and Media
Wed, 04/27/16 - 11:50 am
biosimilars
FDA Licenses a Second Biosimilar – The Parameters of Approval Come Into Better Focus
FDA Law Blog
Thu, 04/7/16 - 09:49 am
FDA
biosimilars
JNJ
Remicade
Inflectra
Pfizer
Celltrion

Pages